Evidence for enhanced neuro-inflammatory processes in neurodegenerative diseases and the action of nitrones as potential therapeutics

  • R. A. Floyd
  • K. Hensley
  • G. Bing
Conference paper


Our attempts to explain the serendipitous observations made on the neuroprotective action of a-phenyl-tert-butyl-nitrone (PBN) several years ago provided a challenge, which lead us to postulate the occurrence of neuroinflammatory processes in the stroked and the aging brain to help explain the results. Surprising observations made earlier by other investigators also forced them to conclude that enhanced neuro-inflammatory processes occur in the Alzheimer’s Disease (AD) brain. Observations we made recently, combined with the early seminal findings and the many others made since, overwhelmingly support the notion that neuro-inflammatory processes occur in the AD brain. Results obtained in our attempts to explain the mechanistic basis of the neuroprotective action of PBN provide strong support for the notion that this compound acts, not by trapping free radicals in a mass-action


Kainic Acid Signal Transduction Process Neuroinflammatory Process Gerbil Brain Kainic Acid Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abe J-L, Kusuhara M, Ulevitch RJ, Berk BC, Lee J-D (1996) Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem 271: 16586–16590PubMedCrossRefGoogle Scholar
  2. Agarwal S, Sohal RS (1994) Aging and proteolysis of oxidized proteins. Arch Biochem Biophys 309: 24–28PubMedCrossRefGoogle Scholar
  3. Aisen PS (1997) Inflammation and Alzheimer’s disease: mechanisms and therapeutic strategies. Gerontology 43: 143–149PubMedCrossRefGoogle Scholar
  4. Aisen PS, Davis KL (1994) Inflammatory mechanisms in Alzheimer’s disease: implications for therapy. Am J Psychiatry 151: 1105–1113PubMedGoogle Scholar
  5. Akama KT, Albanese C, Pestell RG, Van Eldik LJ (1998) Amyloid I3-peptide stimulates nitric oxide production in astrocytes through an NFKB-dependent mechanism. Proc Natl Acad Sci USA 95: 5795–5800PubMedCrossRefGoogle Scholar
  6. Bengzon J, Kokaia Z, Elmer E, Nanobashvili A, Kokaia M, Lindvall O (1997) Apoptosis and proliferation of denate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci USA 94: 10432–10437PubMedCrossRefGoogle Scholar
  7. Bernard C, Wheal HV (1995) Plasticity of AMPA and NMDA receptor-mediated epileptiform activity in a chronic model of temporal lobe epilepsy. Epilepsy Res 21: 95–107PubMedCrossRefGoogle Scholar
  8. Bhat NR, Zhang P, Lee JC, Hogan EL (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor a gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18: 1633–1641PubMedGoogle Scholar
  9. Bianca VD, Dusi S, Bianchini E, Dal Pras I, Rossi F (1999) ß-Amyloid activates the 02 forming NADPH oxidase in microglia, monocytes, and neutrophils. J Biol Chem 274: 15493–15499PubMedCrossRefGoogle Scholar
  10. Bing G, Wilson B, Hudson P, Jin L, Feng Z, Zhang W, Bing R, Jau-Shyong H (1997) A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to one year. Proc Natl Acad Sci USA 94: 9422–9427PubMedCrossRefGoogle Scholar
  11. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB (1988) Demonstration of free radical generation on “stunned” myocardium of intact dogs with the use of the spin trap a-phenyl N-tert-butyl nitrone. J Clin Invest 82: 476–485PubMedCrossRefGoogle Scholar
  12. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature 378: 776–779PubMedCrossRefGoogle Scholar
  13. Butterfield DA, Howard BJ, Yatin S, Allen KL, Carney JM (1997) Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-aphenylnitrone. Proc Natl Acad Sci USA 94: 674–678PubMedCrossRefGoogle Scholar
  14. Cao W, Carney JM, Duchon A, Floyd RA, Chevion M (1988) Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci Lett 88: 233–238PubMedCrossRefGoogle Scholar
  15. Carney JM, Starke-Reed PE, Oliver CN, Landum RW, Cheng MS, Wu JF, Floyd RA (1991) Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound, N-tert-butyl-a-phenylnitrone. Proc Natl Acad Sci USA 88: 3633–3636PubMedCrossRefGoogle Scholar
  16. Carney JM, Tatsuno T, Floyd RA (1992) The role of oxygen radicals in ischemic brain damage: Free radical production, protein oxidation and tissue dysfunction. In: Krieglstein V, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia. Wissenschaftliche Verlagsgesellschaft, Stuttgart, 321–331Google Scholar
  17. Carney JM, Kindy MS, Smith CD, Wood K, Tatsuno T, Wu JF, Landrum WR, Floyd RA (1994) Cerebral ischemia and basic mechanisms. Gene expression and functional changes after acute ischemia: Age-related differences in outcome and mechanisms. In : Yatsu F, Kuschinsky W (eds) Cerebral ischemia and basic mechanisms. Springer, Berlin Heidelberg New York Tokyo, 301–311CrossRefGoogle Scholar
  18. Chen G, Bray TM, Janzen EG, McCay PB (1990) Excretion, metabolism and tissue distribution of a spin trapping agent, a-phenyl-N-tert-butyl-nitrone (PBN) in rats. Free Radic Res Commun 9: 317–323PubMedCrossRefGoogle Scholar
  19. Cheng H-Y, Liu T, Feuerstein G, Barone FC (1993) Distribution of spin-trapping corn-pounds in rat blood and brain: In vivo microdialysis determination. Free Radic Biol Med 14: 243–250PubMedCrossRefGoogle Scholar
  20. Cheung NS, Carroll FY, Larm JA, Beart PM, Giardina SF (1998) Kainate-induced apoptosis correlates with c-Jun activation in cultured cerebellar granule cells. J Neurosci Res 52: 69–82PubMedCrossRefGoogle Scholar
  21. Clough-Helfman C, Phillis JW (1991) The free radical trapping agent N-tert-butyl-aphenylnitrone (PBN) attenuates cerebral ischaemic injury in gerbils. Free Radic Res Commun 15: 177–186PubMedCrossRefGoogle Scholar
  22. Colton CA, Gilbert DL (1987) Production of superoxide anions by a CNS macrophage, the microglia. Fed Eur Biochem Soc 223: 284–288CrossRefGoogle Scholar
  23. Cotman CW, Tenner AJ, Cummings BJ (1996) ß-Amyloid converts an acute phase injury response to chronic injury responses. Neurobiol Aging 17: 723–731PubMedCrossRefGoogle Scholar
  24. Cronin J, Obenaus A, Houser CR, Dudek FE (1992) Electrophysiology of dentate granule cells after kainate-induced synaptic reorganization of the mossy fibers. Brain Res 573: 305–310PubMedCrossRefGoogle Scholar
  25. Da Silva J, Pierrat B, Mary J-L, Lesslauer W (1997) Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 272: 28373–28380PubMedCrossRefGoogle Scholar
  26. Dawson VL, Dawson TM (1996) Pathologic roles of nitric oxide in the central nervous system. Free Radic Brain Physiol Disord: 83–86Google Scholar
  27. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13: 2651–2661PubMedGoogle Scholar
  28. Dubey A, Forster MJ, Sohal RS (1995) Effect of spin-trapping compound N-tert-butyl-aphenylnitrone on protein oxidation and life span. Arch Biochem Biophys 324: 249–254PubMedCrossRefGoogle Scholar
  29. Dubey A, Forster MJ, Sohal RS (1996) Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch Biochem Biophys 333: 189–197PubMedCrossRefGoogle Scholar
  30. Edamatsu R, Mori A, Packer L (1995) The spin-trap N-tert-a-phenyl-butylnitrone prolongs the life span of the senescence accelerated mouse. Biochem Biophys Res Commun 211: 847–849PubMedCrossRefGoogle Scholar
  31. Eikelenboom P, Veerhuis R (1996) The role of complement and activated microglia in the pathogenesis of Alzheimer’s disease. Neurobiol Aging 17: 673–680PubMedCrossRefGoogle Scholar
  32. Eikelenboom P, Rozemuller JM, van Muiswinkel FL (1998) Inflammation and Alzheimer’s disease: relationships between pathogenic mechanisms and clinical expression. Exp Neurol 154: 89–98PubMedCrossRefGoogle Scholar
  33. Endoh H, Fujii S, Suzuki Y, Sato S, Kayama T, Kotake Y, Yoshimura T (1999) Spin trapping agent, phenyl N-tert-butyl nitrone reduces the nitric oxide production in the rat brain of bacterial meningitis model. unknownGoogle Scholar
  34. Finch CE, Marchalonis JJ (1996) Evolutionary perspectives on amyloid nd inflammatory features of Alzheimer’s disease. Neurobiol Aging 17: 809–815PubMedCrossRefGoogle Scholar
  35. Finch CE, Morgan DG (1990) RNA and protein metabolism in the aging brain. Annu Rev Neurosci 13: 75–88PubMedCrossRefGoogle Scholar
  36. Floyd RA (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4: 2587–2597PubMedGoogle Scholar
  37. Floyd RA (1997) Protective action of nitrone based free radical traps against oxidative damage of the central nervous system. In: Sies H (ed) Advances in pharmacology. Academic Press, San Diego, 361–378Google Scholar
  38. Floyd RA (1999a) Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic Biol Med 26: 1346–1355PubMedCrossRefGoogle Scholar
  39. Floyd RA (1999b) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222: 236–245PubMedCrossRefGoogle Scholar
  40. Floyd RA, Carney JM (1996) Nitrone radical traps protect in experimental neurodegenerative diseases. In: Chapman CA, Olanow CW, Jenner P, Youssim M (eds) Neuroprotective approaches to the treatment of Parkinson’s disease and other neurodegenerative disorders. Academic Press, London, 69–90Google Scholar
  41. Forster MJ, Dubey A, Dawson KM, Stutts WA, Lal H, Sohal RS (1996) Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Natl Acad Sci USA 93: 4765–4769PubMedCrossRefGoogle Scholar
  42. Gordon MN, Schreier WA, Ou X, Holcomb LA, Morgan DG (1997) Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat. J Comp Neur 388: 106–119PubMedCrossRefGoogle Scholar
  43. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ (1996) Activation of mitogenactivated protein kinase by H2O2: Role in cell survival following oxidant injury. J Biol Chem 271: 4138–4142PubMedCrossRefGoogle Scholar
  44. Hensley K, Carney JM, Mattson M, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA (1994) A model for ß-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc Natl Acad Sci USA 91: 3270–3274PubMedCrossRefGoogle Scholar
  45. Hensley K, Pye Q, Tabatabaie T, Stewart CA, Floyd RA (1996) Reactive oxygen involvement in neurodegenerative pathways: Causes, consequences, and potential management with nitrone-based free radical traps. In: Wood PL (ed) Inflammatory mechanisms and its management. Humana Press, CharlestownGoogle Scholar
  46. Hensley K, Carney JM, Stewart CA, Tabatabaie T, Pye QN, Floyd RA (1997) Nitronebased free radical traps as neuroprotective agents in cerebral ischemia and other pathologies. In: Green AR, Cross AJ (eds) Neuroprotective agents and cerebral ischemia. Academic Press, London, 299–317Google Scholar
  47. Hensley K, Maidt ML, Yu Z, Markesbery WR, Floyd RA (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18: 8126–8132PubMedGoogle Scholar
  48. Hensley K, Floyd RA, Zheng N-Y, Nael R, Robinson KA, Nguyen X, Pye QN, Stewart CA, Geddes J, Markesbery WR, Patel E, Johnson GVW, Bing G (1999) p38 Kinase is activated in the Alzheimer’s disease brain. J Neurochem 72: 2053–2058PubMedCrossRefGoogle Scholar
  49. Hsu SM, Raine L, Fanger HJ (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. Histochem Cytochem 29: 480–577Google Scholar
  50. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Scarpace PJ, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AI (1999) The Aß peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction. Biochem 38: 7609–7616CrossRefGoogle Scholar
  51. Huot J, Houle F, Marceau F, Landry J (1997) Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathyway in vascular edothelial cells. Circul Res 80: 383–392CrossRefGoogle Scholar
  52. Iadecola C, Zhang F, Xu S, Casey R, Ross ME (1995a) Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 15: 378–384PubMedCrossRefGoogle Scholar
  53. Iadecola C, Zhang F, Xu X (1995b) Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 268: R286–R292PubMedGoogle Scholar
  54. Janzen EG, Blackburn BJ (1969) Detection and identification of short-lived free radicals by electron spin resonance trapping techniques (spin trapping). Photolysis of organolead, -tin, and -mercury compounds. J Am Chem Soc 91: 4481–4490CrossRefGoogle Scholar
  55. Janzen EG, West MS, Poyer JL (1994) Comparison of antioxidant activity of PBN with hindered phenols in initiated rat liver microsomal lipid peroxidation. In: Asada K, Toshikawa T (eds) Frontiers of reactive oxygen species in biology and medicine. ElsevierGoogle Scholar
  56. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, Nishida E (1997) Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 272: 18518–18521PubMedCrossRefGoogle Scholar
  57. Kotake Y, Sang H, Miyajima T, Wallis GL (1998) Inhibition of NF-KB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN). Biochem Biophys Acta 1448: 77–84PubMedCrossRefGoogle Scholar
  58. Kummer JL, Rao PK, Heidenreich KA (1997) Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 272: 20490–20494PubMedCrossRefGoogle Scholar
  59. Kuroda S, Tsuchidate R, Smith M-L, Maples KR, Siesjo BK (1999) Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 19: 778–787PubMedCrossRefGoogle Scholar
  60. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364: 535–537PubMedCrossRefGoogle Scholar
  61. Lai EK, McCay PB, Noguchi T, Fong K-L (1979) In vivo spin-trapping of trichloromethyl radicals formed from CC14. Biochem Pharmacol 28: 2231–2235PubMedCrossRefGoogle Scholar
  62. Lai EK, Crossley C, Sridhar R, Misra HP, Janzen EG, McCay PB (1986) In vivo spin trapping of free radicals generated in brain, spleen, and liver during gamma radiation of mice. Arch Biochem Biophys 244: 156–160PubMedCrossRefGoogle Scholar
  63. Lipton SA, Choi Y-B, Pan Z-H, Lei SZ, Chen H-S V, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364: 626–632PubMedCrossRefGoogle Scholar
  64. McGeer PL, Itagaki S, Tago H, McGreer EG (1987) Reactive microglia in patients with senile dementia of the Alzheimer’s type are positive for the histocompatability of glycoprotein HLA-DR. Neurosci Lett 79: 195–200PubMedCrossRefGoogle Scholar
  65. McGeer PL, Akiyama H, Itagaki S, McGreer EG (1989a) Immune system response in Alzheimer’s disease. Can J Neurol Sci 16: 516–527PubMedGoogle Scholar
  66. McGeer PL, Akiyama H, Itagaki S, McGreer EG (1989b) Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 107: 341–346PubMedCrossRefGoogle Scholar
  67. McGeer PL, McGreer E, Rogers J, Sibley J (1990) Anti-inflammatory drugs and Alzheimer disease. Lancet 335 8696: 1037PubMedCrossRefGoogle Scholar
  68. McGeer PL, Schulzer M, McGreer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology 47: 425–432PubMedCrossRefGoogle Scholar
  69. Mason GG, Rivett AJ (1994) Proteasomes: the changing face of proteolysis. Chem Biol 4: 197–199CrossRefGoogle Scholar
  70. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 23: 134–147PubMedCrossRefGoogle Scholar
  71. Mathis C, Ungerer A (1992) Comparative analysis of seizures induced by intracerebroventricular administration of NMDA, kainate and quisqualate in mice. Exp Brain Res 88: 277–282PubMedCrossRefGoogle Scholar
  72. Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K (1997) Activation of NFIcB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxinitrite production and protein nitration. J Neurosci Res 49: 681–697PubMedCrossRefGoogle Scholar
  73. Miyajima T, Kotake Y (1995) Spin trapping agent, phenyl N-tert-butyl nitrone, inhibits induction of nitric oxide synthase in endotoxin-induced shock in mice. Biochem Biophys Res Commun 215: 114–121PubMedCrossRefGoogle Scholar
  74. Monti E, Cova D, Guido E, Morelli R, Oliva C (1996) Protective effect of the nitroxide tempol against the cardiotoxicity of adriamycin. Free Radic Biol Med 21: 463–470CrossRefGoogle Scholar
  75. Morgan TE, Xie Z, Goldsmith S, Yoshida T, Lanzrein A-S, Stone D, Rozovsky I, Perry G, Smith MA, Finch CE (1999) The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neurosci 89: 687–699CrossRefGoogle Scholar
  76. Oliver CN, Fulks RM, Levine RL, Fucci L, Rivett, Roseman JE, Stadtman ER (1984) Oxidative inactivation of key metabolic enzymes during aging. In: Roy AK, Choitterjee B (eds) Molecular basis of aging. Academic Press, New York, 237–254Google Scholar
  77. Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carney JM, Floyd RA (1990) Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci USA 87: 5144–5147PubMedCrossRefGoogle Scholar
  78. Pasinetti GM (1996) Inflammatory mechanisms in neurodegeneration and Alzheimer’s Disease: the role of the complement system. Neurobiol Aging 17: 707–716PubMedCrossRefGoogle Scholar
  79. Phillis JW, Clough-Helfman C (1990a) Free Radicals and ischaemic brain injury: protec-tion by the spin trap agent PBN. Med Sci Res 18: 403–404Google Scholar
  80. Phillis JW, Clough-Helfman C (1990b) Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-a-phenylnitrone (PBN). Neurosci Lett 116: 315–319PubMedCrossRefGoogle Scholar
  81. Pisa M, Sanberg PR, Corcoran ME, Fibiger HC (1980) Spontaneously recurrent seizures after intracerebral injections of kainic acid in rat: A possible model of human temporal lobe epilepsy. Brain Res 200: 481–487PubMedCrossRefGoogle Scholar
  82. Poyer JL, Floyd RA, McCay PB, Janzen EG, Davis ER (1978) Spin trapping of the trichloromethyl radical produced during enzymic NADPH oxidation in the presence of carbon tetrachloride or carbon bromotrichloromethane. Biochim Biophys Acta 539: 402–409PubMedCrossRefGoogle Scholar
  83. Poyer JL, McCay PB, Lai EK, Janzen EG, Davis ER (1980) Confirmation of assignment of the trichloromethyl radical spin adduct detected by spin trapping during 13c-carbon tetrachloride metabolism in vitro and in vivo. Biochem Biophys Res Commun 94: 1154–1160PubMedCrossRefGoogle Scholar
  84. Qin ZH, Wang Y, Nakai M, Chase TN (1998) Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum. Mol Pharmacol 53: 33–42PubMedGoogle Scholar
  85. Racine R, Okujava V, Chipashvili S (1972) Modification of seizure activity by electrical stimulation 3. Mechanisms Electroencephalogr Clin Neurophysiol 32: 295–299CrossRefGoogle Scholar
  86. Raingeaud J, Gupta S, Rogers JS, Martin D, Han J, Ulevitch RJ, Davis RJ (1995) Proinflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420–7426PubMedCrossRefGoogle Scholar
  87. Rice N, Ernst MK (1993) In vivo control of NFKB activation by IxBa. EMBO J 12: 4685–4695PubMedGoogle Scholar
  88. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL, Saklatvala J (1997) Actions of IL-1 are selectively controlled by p38 mitogenactivated protein kinase. Am Assoc Immunologists 158: 3165–3173Google Scholar
  89. Rivett AJ (1985) Purificatoin of a liver alkaline protease which degrades oxidatively modified glutamine synthetase. Characterization as a high molecular weight cysteine proteinase. J Biol Chem 260: 12600–12606PubMedGoogle Scholar
  90. Rivett AJ (1989) The multicatalytic proteinase of mammalian cells. Arch Biochem Biophys 268: 1–8PubMedCrossRefGoogle Scholar
  91. Robinson KA, Stewart CA, Pye QN, Nguyen X, Kenney L, Salzman S, Floyd RA, Hensley K (1999a) Redox sensitive protein phosphatase activity regulates the phosphorylation state of p38 protein kinase in primary astrocyte culture. J Neurosci Res 55: 724–732PubMedCrossRefGoogle Scholar
  92. Robinson KA, Stewart CA, Pye QN, Floyd RA, Hensley K (1999b) Basal protein phosphorylation is decreased and phosphatase activity increased by an antioxidant and a free radical trap in primary rat glia. Arch Biochem Biophys 365: 211–215PubMedCrossRefGoogle Scholar
  93. Rogers J, O’Barr S (1997) Chapter 11: Inflammatory mediators in Alzheimer’s disease. In: Wasco W, Tanzi RE (eds) Molecular mechanisms of dementia. Humana Press, Charlestown, 1997, pp 177–198Google Scholar
  94. Rogers J, Cooper NR, Webster S, Schultz J, McGreer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, Lieberburg I (1992) Complement activation by aamyloid in Alzheimer disease. Proc Natl Acad Sci USA 89: 10016–10020PubMedCrossRefGoogle Scholar
  95. Rogers J, Webster S, Lue L-F, Brachova L, Civin WH, Emmerling M, Shivers B, Walker D, McGreer P (1996) Inflammation and Alzheimer’s disease pathogenesis. Neurobiol Aging 17: 681–686PubMedCrossRefGoogle Scholar
  96. Rozovsky I, Finch CE, Morgan TE (1998) Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol Aging 19: 97–103PubMedCrossRefGoogle Scholar
  97. Sack CA, Socci DJ, Crandall BM, Arendash GW (1996) Antioxidant treatment with phenyl-a-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats. Neurosci Lett 205: 181–184PubMedCrossRefGoogle Scholar
  98. Saito K, Yoshioka H, Cutler RG (1998) A spin trap, N-tert-butyl-a-phenylnitrone extends the life span of mice. Biosci Biotechnol Biochem 62: 792–794PubMedCrossRefGoogle Scholar
  99. Schulz JB, Henshaw DR, Siwek D, Jenkins BG, Ferrante RJ, Cipolloni PB, Kowall NW, Rosen BR, Beal MF (1995) Involvement of free radicals in excitotoxicity in vivo. J Neurochem 64: 2239–2247PubMedCrossRefGoogle Scholar
  100. Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S (1997) Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 198: 35–49PubMedCrossRefGoogle Scholar
  101. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik EY, Vilcek J (1997) Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 94: 2869–2873PubMedCrossRefGoogle Scholar
  102. Schwob JE, Fuller T, Price JL, Olney JW (1980) Widespread patterns of neuronal damage following systemic or intracerebral injections of kaiinic acid: A histological study. Neuroscience 5: 991–1014PubMedCrossRefGoogle Scholar
  103. Simonian NA, Getz RI, Leveque JC, Konradi C, Coyle JT (1996) Kainic acid induces apoptosis in neurons. Neuroscience 75: 1047–1055PubMedCrossRefGoogle Scholar
  104. Slater AFG, Nobel CS, Maellaro E, Bustamante J, Kimland M, Orrhenius S (1995) Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis. Biochem J 306: 771–779PubMedGoogle Scholar
  105. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer’s disease. Proc Natl Acad Sci USA 88: 10540–10543PubMedCrossRefGoogle Scholar
  106. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer’s. Nature 382: 120–121PubMedCrossRefGoogle Scholar
  107. Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J Neurosci 17(8): 2653–2657PubMedGoogle Scholar
  108. Socci DJ, Crandall BM, Arendash GW (1995) Chronic antioxidant treatment improves the cognitive performance of aged rats. Brain Res 693: 88–94PubMedCrossRefGoogle Scholar
  109. Sommer W (1880) Erkrankung des Ammonshorns als aetiologisches Moment der Epilepsie Arch Psychiatr Nervenkrankh 10: 631–675Google Scholar
  110. Sonnenberg J, MacGregor-Leon P, Curran T, Morgan J (1989) Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron 3: 359–365PubMedCrossRefGoogle Scholar
  111. Sperk G, Lassmann H, Baran H, Seitelberger F, Hornykiewicz O (1996) Kainic acid-induced seizures: Dose-relationship of behavioral, neurochemical and histopathological changes. Brain Res 338: 289–295CrossRefGoogle Scholar
  112. Stadtman ER (1992) Protein oxidation and aging. Science 257: 1220–1224PubMedCrossRefGoogle Scholar
  113. Stewart CA, Hyam K, Wallis G, Sang H, Robinson KA, Floyd RA, Kotake K, Hensley K (1999) Phenyl-N-tert-butylnitrone demonstrates broad-spectrum inhibition of apoptosis-associated gene expression in endotoxin-treated rats. Arch Biochem Biophys 365: 71–74PubMedCrossRefGoogle Scholar
  114. Suzuki YJ, Mizuno M, Packer L (1994) Signal transduction for nuclear factor-KB activetion: Proposed location of antioxidant-inhibitable step. J Immunol 153: 5008–5015PubMedGoogle Scholar
  115. Suzuki YJ, Forman HJ, Sevanian A (1997) Oxidants as stimulators of signal transduction. Free Radic Biol Med 22: 269–285PubMedCrossRefGoogle Scholar
  116. Tabatabaie T, Stewart C, Pye Q, Kotake Y, Floyd RA (1996) In vivo trapping of nitric oxide in the brain of neonatal rats treated with the HIV-1 envelope protein gp 120: Protective effects of a-phenyl-tert-butylnitrone. Biochem Biophys Res Commun 221: 386–390PubMedCrossRefGoogle Scholar
  117. Tan J, Town T, Paris D, Mori T, Suo Z, Crawford F, Mattson MP, Flavell RA, Mullan M (1999) Microglial activation resulting from CD40–CD40L interaction after [3-amyloid stimulation. Science 286: CD40–CD40PubMedCrossRefGoogle Scholar
  118. Tooyama I, Kimura H, Akiyama H, McGreer PL (1990) Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer’s disease. Brain Res 523: 273–280PubMedCrossRefGoogle Scholar
  119. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNFa-induced apoptosis by NFKB. Science 274: 787–789PubMedCrossRefGoogle Scholar
  120. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Haegeman G (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappa B p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273: 3285–3290PubMedCrossRefGoogle Scholar
  121. Walton KM, DiRocco R, Bartlett BA, Koury E, Marcy VR, Jarvis B, Schaefer EM, Bhat RV (1998) Activation of p38MAPK in microglia after ischemia. J Neurochem 70: 1764–1767PubMedCrossRefGoogle Scholar
  122. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldrin AS (1998) NF-KB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680–1683PubMedCrossRefGoogle Scholar
  123. White AR, Multhaup G, Maher F, Bellingham S, Camakaris J, Zheng H, Bush AI, Beyreuther K, Masters CL, Cappai R (1999) The Alzheimer’s disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J Neurosci 19: 9170–9179PubMedGoogle Scholar
  124. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326–1331PubMedCrossRefGoogle Scholar
  125. Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakie P, Flavell RA (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk 3 gene. Nature 389: 865–870PubMedCrossRefGoogle Scholar
  126. Zhao Q, Pahlmark K, Smith M-I, Siesjo BK (1994) Delayed treatment with the spin trap a-phenyl-N-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats. Acta Physiol Scand 152: 349–350PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2000

Authors and Affiliations

  • R. A. Floyd
    • 1
    • 2
  • K. Hensley
    • 2
  • G. Bing
    • 2
  1. 1.Free Radical Biology and Aging Research ProgramOklahoma Medical Research FoundationOklahoma CityUSA
  2. 2.Department of Biochemistry and Molecular BiologyUniversity of Oklahoma Health Sciences CenterOklahoma CityUSA

Personalised recommendations